Skip to main content
Antares Vision logo

Antares Vision — Investor Relations & Filings

Ticker · AV ISIN · IT0005366601 LEI · 815600807B866042D307 XMIL Manufacturing
Filings indexed 826 across all filing types
Latest filing 2020-12-16 M&A Activity
Country IT Italy
Listing XMIL AV

About Antares Vision

https://www.antaresvision.com/

Antares Vision Group provides technology solutions focused on product quality control and supply chain transparency. The company develops, produces, and maintains integrated systems for inspection, track & trace, and smart data management. Its portfolio includes visual inspection machines designed to ensure product quality and integrity on production lines, as well as comprehensive hardware and software solutions for serialization to meet global regulatory compliance. Leveraging technologies such as Artificial Intelligence (AI), the group offers a data intelligence platform to enhance line efficiency and production quality. Antares Vision Group serves various sectors, primarily life sciences (pharmaceuticals, medical devices) and Fast-Moving Consumer Goods (FMCG), enabling end-to-end traceability and data-driven factory management.

Recent filings

Filing Released Lang Actions
IL GRUPPO ANTARES VISION PROSEGUE LA PROPRIA STRATEGIA DI INTEGRAZIONE DELLE TECNOLOGIE D’ISPEZIONE PIU’ INNOVATIVE: ANTARES VISION INC. ACQUISTA APPLIED VISION CORP.
M&A Activity Classification · 98% confidence The document is explicitly titled and formatted as a "PRESS RELEASE" and details a significant corporate action: the acquisition of Applied Vision Corp. by Antares Vision Inc. This type of announcement, detailing a merger or acquisition, directly corresponds to the 'M&A Activity' category. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a general regulatory announcement (RNS). The content focuses entirely on the transaction details, strategic rationale, and financial impact of the takeover, fitting the definition for TAR (M&A Activity).
2020-12-16 Italian
ANTARES VISION: OTTENUTO IL RINNOVO DELL’ ACCORDO RELATIVO AL PATENT BOX 2021-2025
Regulatory Filings Classification · 95% confidence The document is titled "PRESS RELEASE" and announces a specific corporate event: the renewal of the 'Patent Box' tax incentive agreement for the period 2021-2025 with the Italian Revenue Agency (Agenzia delle Entrate). This is a specific, material corporate update that is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). It is a general announcement concerning regulatory/tax matters and corporate operations. Given the options, it fits best as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the tax benefit is viewed as a financial structure element, but RNS is the most appropriate fallback for specific, non-standard regulatory announcements not covered by other codes. Since it is a press release announcing a specific administrative/tax outcome, RNS (Regulatory Filings - general regulatory announcements) is the best fit.
2020-12-11 Italian
ANTARES VISION: SOTTOSCRITTO ACCORDO RELATIVO AL PATENT BOX 2016-2020
Regulatory Filings Classification · 95% confidence The document is explicitly titled "PRESS RELEASE" and announces a specific corporate event: the signing of a preventive agreement regarding the 'Patent Box' tax incentive for the years 2016-2020, detailing the estimated fiscal benefit (€7.8 million). This is a material, non-periodic announcement concerning financial/tax matters, but it is not a full financial report (like 10-K or IR), a transcript (CT), or a formal dividend notice (DIV). It is a specific update on a financial/tax matter. While it relates to financial results, it is primarily an announcement of a regulatory/tax agreement outcome. Given the options, this type of specific, material corporate news release that doesn't fit the core financial reports (10-K, IR, ER) or specific actions (DIV, CAP, SHA) is best categorized as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the tax benefit is viewed as a financing event. However, since it is a press release announcing a specific agreement with the Italian Revenue Agency (Agenzia delle Entrate) regarding tax benefits, it functions as a significant regulatory/corporate disclosure. Since RNS is the general regulatory fallback and this is not a standard earnings release (ER) or interim report (IR), RNS is the most appropriate fit for a specific, non-standard regulatory announcement.
2020-12-10 Italian
MODALITÀ E RAPPORTO DI ESERCIZIO DEI WARRANT ANTARES VISION
Share Issue/Capital Change Classification · 99% confidence The document is titled "PRESS RELEASE" and details the calculation of the Exercise Ratio ('Rapporto di Esercizio') for Antares Vision Warrants based on the average monthly price for November 2020. It provides specific instructions on how and when to exercise the warrants for December 2020, including payment details (IBAN). This is a specific corporate action announcement related to financing instruments (warrants) and capital structure, rather than a full financial report (10-K, IR) or a general earnings announcement (ER). It fits best under Capital/Financing Update (CAP) as it directly concerns the terms and exercise of outstanding capital instruments (warrants). It is not a general regulatory filing (RNS) because it is highly specific to a corporate financing event.
2020-12-02 Italian
ANTARES VISION RAFFORZA IL POSIZIONAMENTO NELLA TRACCIATURA: VERRANNO ACQUISITI GLI ASSET DI ADENTS
M&A Activity Classification · 99% confidence The document is explicitly titled "PRESS RELEASE" and announces the acquisition of assets from Adents High Tech International by Antares Vision. This type of announcement, detailing a significant corporate transaction (M&A activity), is typically released via a press release to inform the market. While it discusses strategic growth, the core event is the acquisition. This fits best under the M&A Activity category (TAR). It is not a formal regulatory filing like a 10-K, nor is it a general regulatory announcement (RNS) since it concerns a specific, major corporate action. It is too detailed to be a simple Report Publication Announcement (RPA).
2020-11-12 Italian
MODALITÀ E RAPPORTO DI ESERCIZIO DEI WARRANT ANTARES VISION
Share Issue/Capital Change Classification · 99% confidence The document is titled "PRESS RELEASE" and discusses the calculation of the Exercise Ratio ('Rapporto di Esercizio') for Antares Vision Warrants based on the average monthly price for October 2020. It details the subscription price, the process for exercising warrants in November 2020, and the resulting change in share capital after previous exercises. This content relates directly to the company's capital structure and financing instruments (warrants), specifically detailing the mechanics of share issuance resulting from warrant conversion. This fits best under 'Capital/Financing Update' (CAP), as it is a specific announcement detailing the financial mechanics of a capital instrument, rather than a general announcement of fundraising (CAP) or a general share issue (SHA). Since it is a detailed press release about the mechanics of warrant conversion and resulting share capital change, CAP is the most appropriate specific code. It is not a general regulatory filing (RNS) because it is highly specific to a financing event.
2020-11-03 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.